stockrowH. B. Fuller Company
FUL Basic Materials Specialty Chemicals
H. B. Fuller Company’s revenue for fiscal 2025 (year ended November 2025) was $3.5 billion, down 2.67% from fiscal 2024.
- Revenue
- +5.17%
- EPS
- +18.2%
- Free cash flow
- −58.4%
- Total debt
- −1.25%
Quarter to August 2026, against a year earlier
Follow FUL
Alert me
H. B. Fuller Company (FUL) EPS (diluted)
H. B. Fuller Company's EPS (diluted) for fiscal 2025 was $2.75, up 19.6% from $2.30 in fiscal 2024. Over the twelve months to 31 August 2026 it was $3.59. Over the past ten years it has ranged from $1.13 (fiscal 2017) to $3.29 (fiscal 2018); the current reading is higher than 73% of that period. H. B. Fuller Company ranks 18th of 56 Specialty Chemicals companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $2.75 | 19.57% |
| FY2024 | $2.30 | (11.20%) |
| FY2023 | $2.59 | (20.55%) |
| FY2022 | $3.26 | 0.93% |
| FY2021 | $3.23 | 36.86% |
| FY2020 | $2.36 | (6.35%) |
| FY2019 | $2.52 | (23.40%) |
| FY2018 | $3.29 | 191.15% |
| FY2017 | $1.13 | (53.31%) |
| FY2016 | $2.42 | 43.20% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Aug 2026 | $1.44 | 17.07% |
| May 2026 | $1.23 | 223.68% |
| Feb 2026 | $0.38 | (29.63%) |
| Nov 2025 | $0.54 | (55.69%) |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| WDFC WD-40 Company compare | $6.08 |
| KWR Quaker Houghton compare | $5.59 |
| CBT Cabot Corporation compare | $4.17 |
| HWKN Hawkins, Inc. compare | $4.12 |
| FUL H. B. Fuller Company | $3.59 |
| NGVT Ingevity Corporation compare | $1.47 |
| ASH Ashland Inc. compare | $0.08 |
| CC The Chemours Company compare | −$1.02 |
| CLMT Calumet, Inc. compare | −$1.55 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on FUL
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement